An Amyloid-Like C-Terminal Domain of Thrombospondin-1 Displays CD47 Agonist Activity Requiring Both VVM Motifs†

Biochemistry ◽  
2003 ◽  
Vol 42 (33) ◽  
pp. 10001-10011 ◽  
Author(s):  
J. F. McDonald ◽  
J. M. Dimitry ◽  
W. A. Frazier
2007 ◽  
Vol 214 (3) ◽  
pp. 828-837 ◽  
Author(s):  
Sara Santana Nunes ◽  
Marianna A. Ferrari do Outeiro-Bernstein ◽  
Luiz Juliano ◽  
Francisco Vardiero ◽  
Helena B. Nader ◽  
...  

Structure ◽  
2006 ◽  
Vol 14 (1) ◽  
pp. 33-42 ◽  
Author(s):  
Kemin Tan ◽  
Mark Duquette ◽  
Jin-huan Liu ◽  
Rongguang Zhang ◽  
Andrzej Joachimiak ◽  
...  

1994 ◽  
Vol 5 (4) ◽  
pp. 423-437 ◽  
Author(s):  
J C Adams ◽  
J Lawler

Thrombospondin-1 (TSP-1) is an extracellular matrix glycoprotein that may play important roles in the morphogenesis and repair of skeletal muscle. To begin to explore the role of thrombospondin-1 in this tissue, we have examined the interactions of three rodent skeletal muscle cell lines, C2C12, G8, and H9c2, with platelet TSP-1. The cells secrete thrombospondin and incorporate it into the cell layer in a distribution distinct from that of fibronectin. Myoblasts attach and spread on fibronectin- or thrombospondin-coated substrates with similar time and concentration dependencies. Whereas cells adherent on fibronectin organize actin stress fibers, cells adherent on TSP-1 display prominent membrane ruffles and lamellae that contain radial actin microspikes. Attachment to thrombospondin-1 or the 140-kDa tryptic fragment is mediated by interactions with the type 1 repeats and the carboxy-terminal globular domain. Attachment is not inhibited by heparin, GRGDSP peptide, or VTCG peptide but is inhibited by chondroitin sulphate A. Integrins of the beta 1 or alpha V subgroups do not appear to be involved in myoblast attachment to TSP-1; instead, this process depends in part on cell surface chondroitin sulphate proteoglycans. Whereas the central 70-kDa chymotryptic fragment of TSP-1 does not support myoblast attachment, the carboxy-terminal domain of TSP-1 expressed as a fusion protein in the bacterial expression vector, pGEX, supported myoblast attachment to 30% the level of intact TSP-1. Thrombospondin-4 (TSP-4) is also present in skeletal muscle and a fusion protein containing the carboxy-terminal domain of TSP-4 also supported myoblast adhesion, although this protein was less active on a molar basis than the TSP-1 fusion protein. Thus, the carboxyterminal domain of TSP-1 appears to contain a primary attachment site for myoblasts, and this activity is present in a second member of the thrombospondin family.


Blood ◽  
2005 ◽  
Vol 106 (2) ◽  
pp. 658-667 ◽  
Author(s):  
Anne Saumet ◽  
Mouna Ben Slimane ◽  
Michel Lanotte ◽  
Jack Lawler ◽  
Véronique Dubernard

Abstract By means of its antiangiogenic activity, thrombospondin-1 (TSP-1) exerts indirect antitumoral action on solid tumors. Here, we investigated potential antitumor action in an in vitro cell model for promyelocytic leukemia (NB4-LR1), resistant to retinoid maturation. Purified soluble TSP-1 added to cultures induced a strong dose-dependent growth inhibition and a slowly developing maturation-independent cell death. Recombinant fragments of TSP-1 allowed mapping of these activities to its type 3 repeat/C-terminal domain, features that are distinct from those of TSP-1 action on solid tumors, previously ascribed to the type 1 repeat domain. Cell death in leukemia was characterized as a caspase-independent mechanism, without DNA fragmentation, but phosphatidylserine externalization followed by membrane permeabilization. Mitochondria membrane depolarization was inherent to TSP-1 action but did not produce release of death-promoting proteins (eg, noncaspase apoptosis regulators, apoptosis-induced factor [AIF], endonuclease G, or Omi/HtrA2 or the caspase regulators, cytochrome c or second mitochondrial activator of caspase/direct inhibitor of apoptosis protein-binding protein with low isoelectric point [Smac/DIABLO]). Although detected, reactive oxygen species (ROS) production was likely not involved in the death process. Finally, receptor agonist RFYVVM and RGD peptides indicated that TSP-1 death effects are mediated by membrane receptors CD47 and αvβ3. These results demonstrated a new domain-specific antitumoral activity of TSP-1 on a leukemia cell line, which extends TSP-1 therapeutic potential outside the area of vascularized solid tumors. (Blood. 2005;106:658-667)


PLoS ONE ◽  
2009 ◽  
Vol 4 (8) ◽  
pp. e6840 ◽  
Author(s):  
Adi Tabib ◽  
Alon Krispin ◽  
Uriel Trahtemberg ◽  
Inna Verbovetski ◽  
Mario Lebendiker ◽  
...  

2007 ◽  
Vol 283 (7) ◽  
pp. 3932-3941 ◽  
Author(s):  
Kemin Tan ◽  
Mark Duquette ◽  
Jin-huan Liu ◽  
Kumaran Shanmugasundaram ◽  
Andrzej Joachimiak ◽  
...  

Blood ◽  
2006 ◽  
Vol 108 (9) ◽  
pp. 3112-3120 ◽  
Author(s):  
Shu Shun Li ◽  
Zhiwen Liu ◽  
Mehmet Uzunel ◽  
Karl-Gösta Sundqvist

Abstract Lymphocyte adhesion to cells and extracellular matrix (ECM) via integrins plays a pivotal role for the function of the immune system. We show here that endogenous thrombospondin-1 (TSP-1) is a cell-surface ligand for cis interaction of surface receptors in T lymphocytes controlled by integrins and the T-cell antigen receptor (TCR/CD3). Stimulation of CD3 triggers rapid surface expression of TSP-1 in quiescent T cells, whereas activated cells express TSP-1 constitutively. Endogenous TSP-1 is attached to lipoprotein receptor-related protein 1 (LRP1/CD91) and calreticulin (CRT) on the cell surface through its NH2-terminal domain. Adhesion via integrins to ICAM-1 or ECM components up-regulates TSP turnover dramatically from a low level in nonadherent cells, whereas CD3 stimulation inhibits TSP turnover through interference with CD91/CRT-mediated internalization. Integrin-associated protein (IAP/CD47) is essential for TSP turnover and adhesion through interaction with the C-terminal domain of TSP-1 in response to triggering signals delivered at the NH2-terminal. These results indicate that endogenous TSP-1 connects separate cell-surface receptors functionally and regulates T-cell adhesion.


Sign in / Sign up

Export Citation Format

Share Document